Cognito Therapeutics, a late-stage company pioneering non-invasive optogenetics-based therapies for neurodegenerative diseases, announced today it will present a virtual symposium featuring a panel
A fascinating paper from Gradinaru et al describes a genetically engineered mouse model of Parkinson's disease that expresses a photoreceptor in the neurons of a particular part of the brain - the subthalamic nucleus (STN). This area is widely thought to be the central target of the immensely therapeutic technique for Parkinson's known as deep brain stimulation.
Sparking the future of artificial intelligence: CERN hosts the first edition of the Sparks! Serendipity Forum home.cern - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from home.cern Daily Mail and Mail on Sunday newspapers.
To help celebrate GEN’s 40th Anniversary with this special October issue, we asked scientists and business professionals in academia and industry to give us their reflections, impressions, and insights on the biotechnology industry and the life sciences.
Sparking the future of artificial intelligence: CERN hosts the first edition of the Sparks! Serendipity Forum sciencebusiness.net - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from sciencebusiness.net Daily Mail and Mail on Sunday newspapers.